[
  {
    "ts": "2025-07-28T14:00:17+00:00",
    "headline": "Vertex Pharmaceuticals (VRTX) Reports Next Week: Wall Street Expects Earnings Growth",
    "summary": "Vertex (VRTX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
    "url": "https://finance.yahoo.com/news/vertex-pharmaceuticals-vrtx-reports-next-140017288.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "bd0a982b-9a81-3a0e-acec-e5fd1d1da08a",
      "content": {
        "id": "bd0a982b-9a81-3a0e-acec-e5fd1d1da08a",
        "contentType": "STORY",
        "title": "Vertex Pharmaceuticals (VRTX) Reports Next Week: Wall Street Expects Earnings Growth",
        "description": "",
        "summary": "Vertex (VRTX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
        "pubDate": "2025-07-28T14:00:17Z",
        "displayTime": "2025-07-28T14:00:17Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/21b1f011539d3e31c28282071d344177",
          "originalWidth": 900,
          "originalHeight": 598,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/2yFNHFE.NEelN3EcxccP6Q--~B/aD01OTg7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/21b1f011539d3e31c28282071d344177.cf.webp",
              "width": 900,
              "height": 598,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/tL0vRMsfrFLR6L27GP3atA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/21b1f011539d3e31c28282071d344177.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/vertex-pharmaceuticals-vrtx-reports-next-140017288.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/vertex-pharmaceuticals-vrtx-reports-next-140017288.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "VRTX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-07-28T06:07:34+00:00",
    "headline": "Canaccord Reiterates a Buy Rating on Regeneron Pharmaceuticals (REGN)",
    "summary": "Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the most profitable biotech stocks to invest in now. Canaccord updated estimates on Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) on July 24, reiterating a Buy rating on the stock with an $850 price target. The firm stated that it anticipates weakness to continue in EYLEA sales for Q2 2025, primarily […]",
    "url": "https://finance.yahoo.com/news/canaccord-reiterates-buy-rating-regeneron-060734214.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "0e17e00b-5b14-3da4-84a5-115f7884ad7d",
      "content": {
        "id": "0e17e00b-5b14-3da4-84a5-115f7884ad7d",
        "contentType": "STORY",
        "title": "Canaccord Reiterates a Buy Rating on Regeneron Pharmaceuticals (REGN)",
        "description": "",
        "summary": "Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the most profitable biotech stocks to invest in now. Canaccord updated estimates on Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) on July 24, reiterating a Buy rating on the stock with an $850 price target. The firm stated that it anticipates weakness to continue in EYLEA sales for Q2 2025, primarily […]",
        "pubDate": "2025-07-28T06:07:34Z",
        "displayTime": "2025-07-28T06:07:34Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/9b67531d4ce9e2fbb21fef60675f48d3",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Why Regeneron Pharmaceuticals, Inc. (REGN) Crashed Last Week",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xYTEe3VE6sgZxe9COOwZXw--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/9b67531d4ce9e2fbb21fef60675f48d3.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ku0XeMdDvNCP8FVlwzrrCw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/9b67531d4ce9e2fbb21fef60675f48d3.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/canaccord-reiterates-buy-rating-regeneron-060734214.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/canaccord-reiterates-buy-rating-regeneron-060734214.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "REGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]